CRISPR/Cas9-mediated mutation of the Xenopus laevis genome has enabled the modeling of autosomal recessive (AR) retinal disease for the first time in this species. Here, knockout (KO) methodology specific to X. laevis rhodopsin1 has been optimized for the targeted mutation of three X. laevis genes orthologous to human genes responsible for AR forms of blindness: cdhr1, rpe65, and gnat1. At 14 days post-fertilization (dpf), these KO mutations did not cause retinal degeneration (RD). However, PCDH21 KO led to disorganization of rod outer segment (ROS) discs. RPE65 KO caused a significant reduction in ROS length by 44 dpf (p=8.6E-8) despite normal rod opsin localization, yet no cone death despite cone opsin mislocalization. Electroretinography...
We previously reported autophagic structures in rod photoreceptors expressing a misfolding RHO (rhod...
Retinoblastoma is a pediatric eye tumor in which bi-allelic inactivation of the Retinoblastoma 1 (RB...
Currently, there is no known cure for retinitis pigmentosa (RP). Even if some treatments can slow do...
Mutations in the rhodopsin gene (RHO) are the most common cause of autosomal dominant retinitis pigm...
Xenopus laevis is a commonly used research subject for retinal physiology and cell biology studies, ...
Aim: To examine the utility of gene editing therapies for retinitis pigmentosa using Xenopus laevis ...
Retinitis pigmentosa (RP) is a genetic neurodegenerative disorder that causes progressive cell death...
During the vertebrate visual cycle, all-trans-retinal is exported from photoreceptors to the adjacen...
Aims: Inherited Retinal Disorders represent a difficult target for gene therapy. This study exploits...
Currently, 3.5 million Americans over the age of 40 are blind or visually impaired. Cases of visual ...
Inherited retinal dystrophies (IRDs) are a large and heterogeneous group of degenerative diseases ca...
Mutations in PRPF31 cause autosomal dominant retinitis pigmentosa, an untreatable form of blindness....
Reliable genome editing via Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9 m...
At this time, no molecular targeted therapies exist for treatment of retinoblastoma. This can be, in...
In the United States alone, more than one million people are blind. One of the leading causes of bli...
We previously reported autophagic structures in rod photoreceptors expressing a misfolding RHO (rhod...
Retinoblastoma is a pediatric eye tumor in which bi-allelic inactivation of the Retinoblastoma 1 (RB...
Currently, there is no known cure for retinitis pigmentosa (RP). Even if some treatments can slow do...
Mutations in the rhodopsin gene (RHO) are the most common cause of autosomal dominant retinitis pigm...
Xenopus laevis is a commonly used research subject for retinal physiology and cell biology studies, ...
Aim: To examine the utility of gene editing therapies for retinitis pigmentosa using Xenopus laevis ...
Retinitis pigmentosa (RP) is a genetic neurodegenerative disorder that causes progressive cell death...
During the vertebrate visual cycle, all-trans-retinal is exported from photoreceptors to the adjacen...
Aims: Inherited Retinal Disorders represent a difficult target for gene therapy. This study exploits...
Currently, 3.5 million Americans over the age of 40 are blind or visually impaired. Cases of visual ...
Inherited retinal dystrophies (IRDs) are a large and heterogeneous group of degenerative diseases ca...
Mutations in PRPF31 cause autosomal dominant retinitis pigmentosa, an untreatable form of blindness....
Reliable genome editing via Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9 m...
At this time, no molecular targeted therapies exist for treatment of retinoblastoma. This can be, in...
In the United States alone, more than one million people are blind. One of the leading causes of bli...
We previously reported autophagic structures in rod photoreceptors expressing a misfolding RHO (rhod...
Retinoblastoma is a pediatric eye tumor in which bi-allelic inactivation of the Retinoblastoma 1 (RB...
Currently, there is no known cure for retinitis pigmentosa (RP). Even if some treatments can slow do...